144 related articles for article (PubMed ID: 28841682)
1. Downregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cells.
Zhang S; Zeng N; Alowayed N; Singh Y; Cheng A; Lang F; Salker MS
PLoS One; 2017; 12(8):e0183681. PubMed ID: 28841682
[TBL] [Abstract][Full Text] [Related]
2. SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer.
Cheng Y; Wang X; Wang P; Li T; Hu F; Liu Q; Yang F; Wang J; Xu T; Han W
Tumour Biol; 2016 Jul; 37(7):9919-30. PubMed ID: 26815503
[TBL] [Abstract][Full Text] [Related]
3. SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance.
Sheets JN; Iwanicki M; Liu JF; Howitt BE; Hirsch MS; Gubbels JA; Drapkin R; Egland KA
Oncogenesis; 2016 Oct; 5(10):e264. PubMed ID: 27775699
[TBL] [Abstract][Full Text] [Related]
4. The fate of human SUSD2+ endometrial mesenchymal stem cells during decidualization.
Gorsek Sparovec T; Markert UR; Reif P; Schoell W; Moser G; Feichtinger J; Mihalic ZN; Kargl J; Gargett CE; Gold D
Stem Cell Res; 2022 Apr; 60():102671. PubMed ID: 35093718
[TBL] [Abstract][Full Text] [Related]
5. Sushi Domain Containing 2 (SUSD2) inhibits platelet activation and binding to high-grade serous ovarian carcinoma cells.
Lager TW; Roetman JJ; Kunkel J; Thacker M; Sheets JN; Egland KA; Miles CM; Larson MK; Gubbels JAA
Platelets; 2018 Dec; 29(8):834-837. PubMed ID: 30335544
[TBL] [Abstract][Full Text] [Related]
6. Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against Sushi domain containing 2.
Sivasubramaniyan K; Harichandan A; Schumann S; Sobiesiak M; Lengerke C; Maurer A; Kalbacher H; Bühring HJ
Stem Cells Dev; 2013 Jul; 22(13):1944-54. PubMed ID: 23406305
[TBL] [Abstract][Full Text] [Related]
7.
Sheets JN; Patrick ME; Egland KA
Oncotarget; 2020 Jun; 11(24):2290-2301. PubMed ID: 32595828
[TBL] [Abstract][Full Text] [Related]
8. Multiple functions of sushi domain containing 2 (SUSD2) in breast tumorigenesis.
Watson AP; Evans RL; Egland KA
Mol Cancer Res; 2013 Jan; 11(1):74-85. PubMed ID: 23131994
[TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation.
Manohar M; Fatima I; Saxena R; Chandra V; Sankhwar PL; Dwivedi A
J Nutr Biochem; 2013 Jun; 24(6):940-7. PubMed ID: 22959059
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterisation of maternal perivascular SUSD2
Khanmohammadi M; Mukherjee S; Darzi S; Paul K; Werkmeister JA; Cousins FL; Gargett CE
Cell Tissue Res; 2021 Sep; 385(3):803-815. PubMed ID: 33961124
[TBL] [Abstract][Full Text] [Related]
11. LeftyA sensitive cytosolic pH regulation and glycolytic flux in Ishikawa human endometrial cancer cells.
Salker MS; Zhou Y; Singh Y; Brosens J; Lang F
Biochem Biophys Res Commun; 2015 May; 460(3):845-9. PubMed ID: 25838200
[TBL] [Abstract][Full Text] [Related]
12. Human Endometrial Reconstitution From Somatic Stem Cells: The Importance of Niche-Like Cells.
López-Pérez N; Gil-Sanchis C; Ferrero H; Faus A; Díaz A; Pellicer A; Cervelló I; Simón C
Reprod Sci; 2019 Jan; 26(1):77-87. PubMed ID: 29575998
[TBL] [Abstract][Full Text] [Related]
13. Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling.
Xiong S; Klausen C; Cheng JC; Zhu H; Leung PC
Oncotarget; 2015 Oct; 6(31):31659-73. PubMed ID: 26384307
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinoma.
Liu XR; Cai CX; Luo LM; Zheng WL; Shi R; Zeng J; Xu YQ; Wei M; Ma WL
Cancer Cell Int; 2016; 16():15. PubMed ID: 26933386
[TBL] [Abstract][Full Text] [Related]
15. [Regulation of Bub1 mRNA expression in endometrial carcinoma Ishikawa cells by estrogen and paclitaxel].
Chen YH; Li XP; Wang Y; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):686-90. PubMed ID: 21092550
[TBL] [Abstract][Full Text] [Related]
16. RON, ROR1 and SUSD2 expression in tissues of endometrial carcinoma patients. Clinicopathological and prognostic implications.
Abdelbary AM; Kaf RM; Lashin ME; Alattar AZ; Elsayed DH; Amin AF; Gertallah LM; Yehia AM
Contemp Oncol (Pozn); 2022; 26(2):109-122. PubMed ID: 35903204
[TBL] [Abstract][Full Text] [Related]
17. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
[TBL] [Abstract][Full Text] [Related]
18. Kruppel-like factor 4 (KLF-4) inhibits the epithelial-to-mesenchymal transition and proliferation of human endometrial carcinoma cells.
Wang X; Li X; Huang C; Li L; Qu H; Yu X; Ni H; Cui Q
Gynecol Endocrinol; 2016 Sep; 32(9):772-776. PubMed ID: 27098518
[TBL] [Abstract][Full Text] [Related]
19. The Susd2 protein regulates neurite growth and excitatory synaptic density in hippocampal cultures.
Nadjar Y; Triller A; Bessereau JL; Dumoulin A
Mol Cell Neurosci; 2015 Mar; 65():82-91. PubMed ID: 25724483
[TBL] [Abstract][Full Text] [Related]
20. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
